PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding PDS Biotechnology Corp changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 48 | 55 | +7 |
| Shares | 8.24M | 7.45M | −789.2K (−9.6%) |
| Value | $9.81M | $9.90M | +$96.0K (+1.0%) |
New holders (13)
Institutions that held PDS Biotechnology Corp at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 249,025 | $331.2K | 0.00% |
| Renaissance Technologies LLC | 105,687 | $140.6K | 0.00% |
| Squarepoint Ops LLC | 97,765 | $130.0K | 0.00% |
| Jane Street Group, LLC | 69,251 | $92.1K | 0.00% |
| Marshall Wace, LLP | 68,454 | $91.0K | 0.00% |
| Watts Gwilliam & Co., LLC | 55,000 | $63.3K | 0.01% |
| Virtu Financial LLC | 32,002 | $43.0K | 0.00% |
| Two Sigma Securities, LLC | 22,628 | $30.1K | 0.00% |
| Stratos Wealth Partners, LTD. | 11,303 | $15.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 10,861 | $14.4K | 0.00% |
| Grandfield & Dodd, LLC | 10,000 | $13.3K | 0.00% |
| Rialto Wealth Management, LLC | 400 | $532 | 0.00% |
| Point72 (DIFC) Ltd | 50 | $66 | 0.00% |
Sold out (6)
Institutions that held PDS Biotechnology Corp at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Amussen Hunsaker Associates LLC | 75,016 | $89.3K |
| Ritholtz Wealth Management | 19,659 | $23.4K |
| Simplex Trading, LLC | 7,898 | $9.00K |
| Bessemer Group Inc | 1,146 | $1.00K |
| Hughes Financial Services, LLC | 764 | $825 |
| Northwestern Mutual Wealth Management Co | 257 | $306 |